Live News Categoriesequity

Knight Therapeutics Inc. (GUD.TO) News

Track canonical SquawkNews coverage tagged to GUD.TO, Knight Therapeutics Inc.. This hub brings together deduplicated headlines about toronto, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol GUD.TO Asset equity Sector Markets 90 days 1 Last 10.5 Updated Sep 29, 2026, 11:31 AM UTC Open live news feed

M Knight Therapeutics enters exclusive distribution agreement with Kyowa Kirin for Poteligeo in Latin America Knight Therapeutics says it will seek regulatory approval and then commercialize Poteligeo (mogamulizumab) in Brazil, Mexico, Colombia and Argentina under an exclusive distribution agreement with Kyowa Kirin Internationa EQUITY | Sep 29, 2026, 11:31 AM UTC